MUNICH, Germany & HELSINKI, Finland--(BUSINESS WIRE)--Inveni Capital announced today an investment in Priaxon AG, a Munich, Germany based pharmaceutical service and development company. Inveni Capital was the sole investor in the financing round.
MUNICH, Germany & HELSINKI, Finland--(BUSINESS WIRE)--Inveni Capital announced today an investment in Priaxon AG, a Munich, Germany based pharmaceutical service and development company. Inveni Capital was the sole investor in the financing round.